Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 13,214.00p on 02-06-2026 at 18:35:09
Change -220.00p -1.64%
Buy 13,238.00p
Sell 13,234.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Unknown 0.00 at 13,105.73241p
Day's Volume: 1,916,142
Last Close: 13,214.00p
Open: 13,432.00p
ISIN: GB0009895292
Day's Range 13,132.00p - 13,444.00p
52wk Range: 10,104.00p - 15,730.00p
Market Capitalisation: £204.93b
VWAP: 13,348.84813p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 0 13,105.73241p SI Trade
Currency Conversion
 19:12:27 - 02-Jun-26
Unknown* 0 13,126.54106p Currency Conversion
OTC Trade
 19:10:46 - 02-Jun-26
Unknown* 0 13,107.96191p Currency Conversion
OTC Trade
 19:06:14 - 02-Jun-26
Unknown* 0 13,090.86909p SI Trade
Currency Conversion
 18:53:19 - 02-Jun-26
Unknown* 0 13,093.84175p SI Trade
Currency Conversion
 18:49:55 - 02-Jun-26
Unknown* 3 13,091.61226p SI Trade
Currency Conversion
 18:48:55 - 02-Jun-26
Unknown* 0 13,094.58492p SI Trade
Currency Conversion
 18:48:39 - 02-Jun-26
Unknown* 0 13,096.07125p SI Trade
Currency Conversion
 18:48:38 - 02-Jun-26
Unknown* 4 13,099.04392p SI Trade
Currency Conversion
 18:48:31 - 02-Jun-26
Unknown* 0 13,114.6504p SI Trade
Currency Conversion
 18:48:05 - 02-Jun-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
2nd Jun 2026 (Tue) 13,432.00 13,444.00 13,132.00 13,214.00 1,916,142
1st Jun 2026 (Mon) 13,702.00 13,724.00 13,380.00 13,434.00 1,397,982
29th May 2026 (Fri) 13,812.00 13,916.00 13,760.00 13,802.00 4,555,449
28th May 2026 (Thu) 13,750.00 13,806.00 13,558.00 13,736.00 1,712,873
27th May 2026 (Wed) 13,922.00 14,026.00 13,818.00 14,008.00 3,289,267
26th May 2026 (Tue) 14,044.00 14,080.00 13,878.00 13,960.00 1,927,652
25th May 2026 (Mon) 13,916.00 13,916.00 13,916.00 13,916.00 0
22nd May 2026 (Fri) 14,106.00 14,118.00 13,884.00 13,916.00 1,151,378
21st May 2026 (Thu) 13,902.00 14,060.00 13,806.00 14,006.00 947,584
20th May 2026 (Wed) 13,780.00 14,052.00 13,762.00 13,950.00 2,022,448
19th May 2026 (Tue) 13,738.00 13,912.00 13,668.00 13,880.00 1,491,117
18th May 2026 (Mon) 13,482.00 13,764.00 13,436.00 13,710.00 1,404,159
15th May 2026 (Fri) 13,800.00 13,862.00 13,528.00 13,632.00 1,864,672
14th May 2026 (Thu) 13,824.00 13,900.00 13,686.00 13,740.00 696,265
13th May 2026 (Wed) 13,674.00 13,814.00 13,584.00 13,766.00 1,571,414
12th May 2026 (Tue) 13,302.00 13,748.00 13,218.00 13,748.00 3,257,436
11th May 2026 (Mon) 13,380.00 13,638.00 13,338.00 13,502.00 3,376,377
8th May 2026 (Fri) 13,342.00 13,466.00 13,188.00 13,344.00 2,521,360
7th May 2026 (Thu) 13,684.00 13,706.00 13,314.00 13,314.00 2,842,072
6th May 2026 (Wed) 13,454.00 13,634.00 13,446.00 13,566.00 1,617,600
5th May 2026 (Tue) 13,564.00 13,566.00 13,276.00 13,330.00 3,363,807
4th May 2026 (Mon) 13,512.00 13,512.00 13,512.00 13,512.00 0
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
1st Jun 2026 3:05 pm RNS Admission of Further Securities to Trading
1st Jun 2026 3:00 pm RNS Total Voting Rights
29th May 2026 7:00 am RNS Imfinzi approved in US for early bladder cancer
27th May 2026 7:00 am RNS US FDA decision date on camizestrant extended
26th May 2026 7:00 am RNS Enhertu recommended in EU for HER2+ solid tumours
26th May 2026 7:00 am RNS Camizestrant recommended for breast cancer in EU
26th May 2026 7:00 am RNS Datroway approved in US for 1L triple-negative BC
18th May 2026 3:00 pm RNS Director/PDMR Shareholding
18th May 2026 7:05 am RNS Enhertu approved in two HER2+ early BC settings
18th May 2026 7:00 am RNS Baxfendy approved in the US for hypertension
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

AstraZeneca breast cancer drug camizestrant shows "sustained" benefit

2nd Jun 2026 13:55

(Alliance News) - AstraZeneca PLC on Tuesday reported encouraging test results for its breast cancer treatment camizestrant. Read More

BSF Enterprise shares jump on paper in praise of "T-rex leather"

2nd Jun 2026 12:02

(Alliance News) - BSF Enterprise on Tuesday saw its shares rise after the publication of a paper on one of its subsidiaries' synthetic leather products. Read More

AstraZeneca hails Imfinzi and Imjudo liver cancer trial results

1st Jun 2026 13:54

(Alliance News) - AstraZeneca PLC on Monday posted positive phase-three trial results for a combination of its drugs Imfinzi and Imjudo to treat a form of liver cancer. Read More

EARNINGS: Polar Capital Global Healthcare lags benchmark index

29th May 2026 16:42

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

AstraZeneca highlights data insights from Cares clinical programme

29th May 2026 14:35

(Alliance News) - AstraZeneca PLC on Friday announced that the CARES phase 3 clinical programme did not meet a primary endpoint, but noted insightful data. Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,373.51
Change34.56

Login to your account

Forgot Password?

Not Registered